TABLE 8.
SNPs | Genotype | Control group | CHD group | t | p | ||
---|---|---|---|---|---|---|---|
n | PDGF‐BB (pg/ml) | n | PDGF‐BB (pg/ml) | ||||
rs1800817 | AA | 81 | 220.02 ± 105.72 | 215 | 259.89 ± 132.60 | −2.430 | 0.016* |
AC + CC | 7 | 271.27 ± 171.76 | 32 | 248.13 ± 132.73 | 0.397 | 0.694 | |
T | −1.166 | 0.468 | |||||
p | 0.247 | 0.640 | |||||
rs2285094 | TT | 54 | 231.92 ± 129.79 | 148 | 255.37 ± 123.55 | −1.178 | 0.240 |
TC | 29 | 215.09 ± 79.30 | 91 | 261.37 ± 148.94 | −1.600 | 0.112 | |
CC | 5 | 191.81 ± 45.43 | 8 | 279.56 ± 97.42 | −1.868 | 0.089 | |
F | 0.429 | 0.163 | |||||
p | 0.653 | 0.850 |
Note: PDGF‐BB level was shown by mean ± SD, and that between control group and CHD group of different genotypes was analyzed by t test (*p < 0.05). In control group or CHD group, the comparison between genotype AA group and genotype AC + CC group was analyzed by t test, and that among genotype TT, TC, CC groups was analyzed by univariate ANOVA (*p < 0.05).
Abbreviations: CHD, coronary heart disease; PDGF‐BB, platelet‐derived growth factor‐BB; SNP, single nucleotide polymorphism.